Royal Bank of Canada
TWST icon

Royal Bank of Canada’s Twist Bioscience TWST Stock Holding History

Royal Bank of Canada’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.43M Sell
30,178
-3,056
-9% -$137K ﹤0.01% 3348
2025
Q4 		$1.05M Sell
33,234
-95,256
-74% -$2.97M ﹤0.01% 3611
2025
Q3 		$3.62M Sell
128,490
-48,814
-28% -$1.48M ﹤0.01% 2914
2025
Q2 		$6.52M Buy
177,304
+136,931
+339% +$4.73M ﹤0.01% 2357
2025
Q1 		$1.58M Buy
40,373
+4,254
+12% +$192K ﹤0.01% 3117
2024
Q4 		$1.68M Buy
36,119
+9,969
+38% +$451K ﹤0.01% 3134
2024
Q3 		$1.18M Sell
26,150
-2,195
-8% -$104K ﹤0.01% 3401
2024
Q2 		$1.4M Buy
28,345
+21,140
+293% +$862K ﹤0.01% 3184
2024
Q1 		$247K Sell
7,205
-10,942
-60% -$395K ﹤0.01% 4512
2023
Q4 		$669K Sell
18,147
-714
-4% -$16.5K ﹤0.01% 4004
2023
Q3 		$382K Buy
18,861
+3,690
+24% +$81.1K ﹤0.01% 4266
2023
Q2 		$311K Buy
15,171
+2,198
+17% +$32.9K ﹤0.01% 4354
2023
Q1 		$195K Sell
12,973
-4,822
-27% -$107K ﹤0.01% 4650
2022
Q4 		$423K Buy
17,795
+8,770
+97% +$254K ﹤0.01% 4258
2022
Q3 		$318K Buy
9,025
+291
+3% +$12.4K ﹤0.01% 4379
2022
Q2 		$305K Sell
8,734
-2,176
-20% -$77.1K ﹤0.01% 4459
2022
Q1 		$539K Sell
10,910
-5,931
-35% -$329K ﹤0.01% 4218
2021
Q4 		$1.3M Sell
16,841
-5,318
-24% -$546K ﹤0.01% 3550
2021
Q3 		$2.37M Buy
22,159
+335
+2% +$38.4K ﹤0.01% 2943
2021
Q2 		$2.91M Buy
21,824
+5,215
+31% +$606K ﹤0.01% 2739
2021
Q1 		$2.06M Buy
16,609
+14,040
+547% +$2.13M ﹤0.01% 2975
2020
Q4 		$363K Sell
2,569
-4,121
-62% -$457K ﹤0.01% 4399
2020
Q3 		$509K Buy
6,690
+3,968
+146% +$247K ﹤0.01% 3837
2020
Q2 		$123K Buy
2,722
+2,551
+1,492% +$91.5K ﹤0.01% 4724
2020
Q1 		$5K Sell
171
-1,412
-89% -$38K ﹤0.01% 6052
2019
Q4 		$33K Buy
+1,583
New +$37K ﹤0.01% 5646
2019
Q3 		– Sell
-243
Closed -$7K – 7131
2019
Q2 		$7K Buy
+243
New +$6.43K ﹤0.01% 6179

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada's TWST Position: Q1 2026 in Review

Royal Bank of Canada reduced its Twist Bioscience (TWST) stake by 9.2% in Q1 2026, selling an estimated $137K and leaving 30,178 shares worth $1.43M. The position accounts for ﹤0.01% of the portfolio, ranked #3348.

Royal Bank of Canada first reported a position in TWST in Q2 2019 and has held it in 27 quarters since. The position peaked at $6.52M in Q2 2025. 280 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Royal Bank of Canada held 30,178 shares of Twist Bioscience worth $1.43M as of Q1 2026.
  • Royal Bank of Canada sold 3,056 Twist Bioscience shares in Q1 2026, an estimated $137K.
  • Twist Bioscience made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3348 holding.
  • Royal Bank of Canada first reported a position in Twist Bioscience in Q2 2019 and has held it in 27 quarters since.
  • Royal Bank of Canada's Twist Bioscience position peaked at $6.52M in Q2 2025.
  • 280 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.